Effectiveness of periodontal treatments on cyclosporine-induced gingival overgrowth in transplant patients

British Dental Journal

Volumn 183, Issue 3, 1997, Pages 89-94

  Somacarrera, M L ^a   Lucas, M ^a   Scully, C ^b   Barrios, C ^c  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ADULT; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EVALUATION; FEMALE; FOLLOW UP; GINGIVA OVERGROWTH; GINGIVITIS; HEART TRANSPLANTATION; HUMAN; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LONGITUDINAL STUDY; MALE; PATHOLOGY; PERIODONTICS; PREVENTIVE DENTISTRY; RANDOMIZED CONTROLLED TRIAL; TOOTH PLAQUE; TREATMENT OUTCOME;

ADULT; CYCLOSPORINE; DENTAL PLAQUE; DENTAL PLAQUE INDEX; DENTAL PROPHYLAXIS; DENTAL SCALING; EVALUATION STUDIES; FEMALE; FOLLOW-UP STUDIES; GINGIVAL OVERGROWTH; GINGIVITIS; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; LONGITUDINAL STUDIES; MALE; PERIODONTAL INDEX; ROOT PLANING; TREATMENT OUTCOME;

EID: 0031561168     PISSN: 00070610     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bdj.4809430     Document Type: Article

References (28)

1. Calne R Y, Rolles K, White D J G et al. Cyclosporin A in clinical organ grafting. Trans Proc 1981; 13: 349-358.
2. Starzl T E, Klintmalm GBG, Porter K A, Iwatsuki S, Schroter G P J. Liver transplant with use of cyclosporin A and prednisone. N Engl J Med 1981; 395:266-269.
3. Seymour R A, Smith D G, Rogers S R. The comparative effects of azathioprine and cyclosporin on some gingival health parameters of renal transplant patients. J Clin Periodontol 1987; 14:610-613.
4. Tyldesley W R, Rotter E. Gingival hyperplasia induced by cyclosporin A. Br Dent J 1984; 157: 305-309.
5. Seymour R A, Smith D G. The effect of a plaque control programme on the incidence and severity of cyclosporin induced gingival changes. J Clin Periodontol 1991; 18: 107-110.
6. Somacarrera M L, Hernández G, Acero J, Moskow B S. Factors related to the incidence and severity of cyclosporin induced gingival overgrowth in transplant patients. A longitudinal study. J Periodontol 1994; 65: 671-675.
7. King G N, Glover M T, Kwan J T C, Williams D M, Thornhill M H. Prevalence and risk factors associated with leukoplakia, hairy leukoplakia, erythematous candidiasis, and gingival hyperplasia in renal transplant recipients. Oral Surg Oral Med Oral Pathol 1994; 78: 18-26.
8. Hefti A F, Eshenaur A E, Hassell T M, Stone C. Gingival overgrowth in cyclosporine A treated multiple sclerosis patients. J Periodontol 1994; 65: 744-749.
9. Daly G C. Resolution of cyclosporin A (CsA)-induced gingival enlargement following reduction in CsA dosage. J Clin Periodontol 1992; 19: 143-145.
10. Somacarrera M L, Lucas M, Acero J. Reversion of gingival hyperplasia in a heart transplant patient upon interruption of cyclosporine therapy. J Spec Care Dent 1996; 16: 18-21.
11. Friskopp J, Klintmaln G. Gingival enlargement. A comparison between cyclosporine and azathioprine treated renal allograft recipients. Swed Dent J 1986; 10:85-92.
12. Daley T D, Wysocki G P, Day C. Clinical and pharmacologic correlations in cyclosporine-induced gingival hyperplasia. Oral Surg Oral Med Oral Patbol 1986; 62: 417-421.
13. O'Leary T J, Drake R B, Naylord J E. The plaque control record. J Periodontol 1972; 43: 38.
14. Lenox J A, Kopczyk R A. A clinical system for scoring a patient's oral hygiene performance. J Am Dent Assoc 1978; 86: 849-852.
15. Somacarrera M L. Estudio clínico-epidemiológico del efecto sobre el periodonto de la terapia con ciclosporina en pacientes trasplantados. pp 227-229. Madrid: Ed. Universidad Complutense, 1992.
16. Somacarrera M L, Hernández G, Acero J, Moskow B S. Localization of gingival overgrowth in heart transplant patients undergoing cyclosporin therapy. J Periodontol 1994; 65: 666-670.
17. Daley T D, Wysocki G P. Cyclosporine therapy: its significance to the periodontist. J Periodontol 1984; 55: 708-712.
18. Seymour R A, Thomason J M, Ellis J S. The pathogenesis of drug-induced gingival overgrowth. J Clin Periodontol 1996; 23: 165-175.
19. Hassell T M, Romberg E, Sobhani S, Lesko L, Douglas R. Lymphocyte-mediated effects of cyclosporin on human fibroblasts. Transplant Proc 1988; 20: 993-1002.
20. Bartold P M. Regulation of human gingival fibroblast growth and synthetic activity by cyclosporine-A in vitro. J Periodont Res 1989; 24: 314-321.
21. Jacobs D, Buchanan J, Cuchens M, Hassell T M. The effect of cyclosporin metabolite OL-17 on gingival fibroblast subpopulations. J Dent Res 1990; 69: 221 (abstr).
22. Seibel W, Yahia N, Stone C, Hassell T M. Elevated protein synthesis of cultured fibroblasts after cyclosporin-A therapy in Beagles. J Dent Res 1989; 68: 288 (abstr).
23. Pernu H E, Knuuttila M, Huttenen K R H, Tiilikainen A S K. Drug-induced 4ingival overgrowth and class II major histocompatibility antigens. Transplantation 1994; 57: 1811-1813.
24. Barclay S, Thomason J M, Idle J R, Seymour R A. The incidence and severity of nifedipine-induced gingival overgrowth. J Clin Periodontol 1992; 19: 311-314.
25. Bullon P, Machuca G, Martinez-Sauquillo A, Rios J V, Velasco E, Rojas J, Lacalle J R. Evaluation of gingival and periodontal conditions following causal periodontal treatment in patients treated with nifedipine and diltiazem. J Clin Periodontol 1996; 23: 649-457.
26. Bullon P, Machuca G, Martinez-Sauquillo A, Rios J V, Rojas J, Lacalle J R. Clinical assessment of gingival hyperplasia in patients treated with nifedipine. J Clin Periodontol 1994; 21: 256-259.
27. Bartold P M. Cyclosporine and gingival overgrowth. J Oral Pathol 1987; 16: 463-468.
28. Yamasaki A, Rose G G, Pinero G J, Mahan C J. Ultrastructure of fibroblast in cyclosporin A induced gingival hyperplasia. J Oral Pathol 1987; 16: 129-134.